What the research shows
- Hepatitis B viral response: 40.6% vs 9.4%
- 88–89% vaccine seroconversion vs 56% alone
- Raised flu-vaccine antibodies in elderly men
Published study results for the compound, not results from this product. For research use only.
Thymosin alpha-1 is conventionally defined as an N-terminally acetylated 28-residue peptide originally isolated from thymosin fraction 5 and studied in thymic and T-cell signalling. The 3mL pen is labelled 25mg but does not state the sequence or confirm N-terminal acetylation. No batch-specific independent report is linked, so identity, quantity and purity are unverified.
- Pack Size
- 3mL
- Product details
- Genovare Catalogue
- Pre-Filled Pen
- Premixed Aqueous
- Storage Guidance
- Follow Package Label
- 1 pre-filled Genovare research pen
- 3 pen needles
- Genovare retail packaging
Genovare Pre-Filled Pen Premixed Aqueous
SpecsThymosin Alpha-1 25mg AQ Pen
Enhanced vaccine responses in human trials
AED 1,350 / pen
Choose your bundle
Minimum order is AED 400
25% off orders of AED 700+ with code KV25 at checkout
Order before 4 PM for same-day Dubai delivery.
UAE delivery: AED 50 below AED 1,000; free from AED 1,000
- Sold by
- Remy Research
- Brand
- Genovare
- Manufacturer
- Genovare
- Tested by
- Independent testing not supplied
Ships from Dubai
Technical Specifications
| Manufacturer | Genovare |
|---|---|
| Compound | Thymosin Alpha-1 |
| Catalogue strength | 25 mg |
| Fill volume | 3mL |
| Format | Aqueous pre-filled pen |
| Pack size | 1 pen with 3 needles |
| Independent testing | Not supplied |